ESC 365 - Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR

ESC Premium Access

Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR

Session: Drug - Eluting stent

Topic: PCI / stents: devices and technique

Speaker: Professor E. Omerovic (Gothenburg, SE)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Elmir Omerovic

Sahlgrenska University Hospital, Gothenburg (Sweden)

14 presentations

0 follower

4 more presentations in this session

State of the art in drug eluting stent technology.

Speaker: Professor R. Byrne (Dublin, IE)

Ten year clinical outcome of a large registry with unrestricted use of DES

Speaker: Professor R. van Geuns (Nijmegen, NL)

Long-term clinical outcomes of biolimus-eluting stents with biodegradable versus bare-metal stents in patients with acute STEMI: 5 Year results of the randomized COMFORTABLE AMI trial.

Speaker: Doctor L. Raber (Bern, CH)

Future direction for research in drug - eluting stent technology.

Speaker: Doctor M. Morice (Massy, FR)

Access the full session

Drug - Eluting stent

Speakers: Professor E. Omerovic, Professor R. Byrne, Professor R. van Geuns, Doctor L. Raber, Doctor M. Morice

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources